162 related articles for article (PubMed ID: 11516864)
41. Single institute experience of chemotherapy and adjuvant radiotherapy for localized aggressive non-Hodgkin's lymphoma: retrospective analysis of the clinical efficacy of radiation therapy.
Kodaira T; Fuwa N; Kamata M; Furutani K; Ogura M; Morishima Y
Am J Clin Oncol; 2002 Dec; 25(6):612-8. PubMed ID: 12478011
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study.
Murthy V; Thomas K; Foo K; Cunningham D; Johnson B; Norman A; Horwich A
Clin Lymphoma Myeloma; 2008 Aug; 8(4):241-5. PubMed ID: 18765312
[TBL] [Abstract][Full Text] [Related]
43. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
44. Radiation therapy for primary orbital lymphoma.
Chao CK; Lin HS; Devineni VR; Smith M
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):929-34. PubMed ID: 7860408
[TBL] [Abstract][Full Text] [Related]
45. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
46. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
47. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
48. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
51. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
52. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
[TBL] [Abstract][Full Text] [Related]
53. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
[TBL] [Abstract][Full Text] [Related]
54. [Current technologies in radiotherapy for non-Hodgkin lymphomas].
Vinogradova IuN
Vopr Onkol; 2013; 59(4):509-12. PubMed ID: 24032229
[TBL] [Abstract][Full Text] [Related]
55. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
56. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
58. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
59. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
Paumier A; Ghalibafian M; Beaudre A; Ferreira I; Pichenot C; Messai T; Lessard NA; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):199-205. PubMed ID: 21481723
[TBL] [Abstract][Full Text] [Related]
60. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
